2022年ESC心脏肿瘤学指南的实用方法。心脏病学和肿瘤学专家团队的评论。
A practical approach to the ESC 2022 cardio-oncology guidelines. Comments by a team of experts: cardiologists and oncologists.
发表日期：2023 Sep 03
作者：
Przemysław Leszek, Aneta Klotzka, Stanisław Bartuś, Paweł Burchardt, Anna M Czarnecka, Monika Długosz-Danecka, Marek Gierlotka, Hanna Koseła-Paterczyk, Agata Krawczyk-Ożóg, Tomasz Kubiatowski, Marcin Kurzyna, Adam Maciejczyk, Przemysław Mitkowski, Aleksander Prejbisz, Piotr Rutkowski, Ewa Sierko, Maciej Sterliński, Sebastian Szmit, Marek Szwiec, Mateusz Tajstra, Agnieszka Tycińska, Adam Witkowski, Wojciech Wojakowski, Bożena Cybulska-Stopa
来源：
Experimental Hematology & Oncology
摘要：
2022年欧洲心脏病学会（ESC）指南[1]是一份由心脏病学和肿瘤学专家共同准备的综合性文件。对于肿瘤患者，根据心脏状况、癌症阶段和潜在的抗癌治疗类型，需要个体化护理。在开始肿瘤治疗之前，应进行心脏护理的优化，并在肿瘤治疗期间以及其完成后长期继续进行[2]。已发表的ESC指南还附有一支波兰心脏病学和肿瘤学专家团队的实践意见。
The 2022 European Society of Cardiology (ESC) guidelines [1] are a comprehensive document, prepared jointly by experts in cardiology and oncology. In the case of an oncological patient, it is necessary to individualize care in relation to the cardiological condition, the stage of the cancer and the type of potential anti-cancer therapy. Cardiac care optimisation should be undertaken before the start of oncological therapy, and continued during oncological therapy, as well as long-term after its completion [2]. The published ESC Guidelines were supplemented with a practical comments of a team of polish cardiology and oncology experts.